David A. Isenberg
AuthID: R-006-E33
31
TITLE: Current pharmacological treatment of idiopathic inflammatory myopathies
AUTHORS: Serena Fasano; Sara Custodio Alves; David A Isenberg;
PUBLISHED: 2016, SOURCE: EXPERT REVIEW OF CLINICAL PHARMACOLOGY, VOLUME: 9, ISSUE: 4
AUTHORS: Serena Fasano; Sara Custodio Alves; David A Isenberg;
PUBLISHED: 2016, SOURCE: EXPERT REVIEW OF CLINICAL PHARMACOLOGY, VOLUME: 9, ISSUE: 4
INDEXED IN: 
WOS 
CrossRef
WOS CrossRef32
TITLE: Musculoskeletal complications of haematological disease
AUTHORS: Sandra A Morais; Hannah E du Preez; Mohammed Rashid Akhtar; Susan Cross; David A Isenberg;
PUBLISHED: 2016, SOURCE: RHEUMATOLOGY, VOLUME: 55, ISSUE: 6
AUTHORS: Sandra A Morais; Hannah E du Preez; Mohammed Rashid Akhtar; Susan Cross; David A Isenberg;
PUBLISHED: 2016, SOURCE: RHEUMATOLOGY, VOLUME: 55, ISSUE: 6
33
TITLE: Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus Full Text
AUTHORS: Farinha, F; Abrol, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 11
AUTHORS: Farinha, F; Abrol, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 11
34
TITLE: Why do patients with myositis die? A retrospective analysis of a single-centre cohort
AUTHORS: Amaral A Silva; Cogollo, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 34, ISSUE: 5
AUTHORS: Amaral A Silva; Cogollo, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 34, ISSUE: 5
INDEXED IN: WOS
WOS35
TITLE: Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review Full Text
AUTHORS: Custodio C Alves; Fasano, S; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 14
AUTHORS: Custodio C Alves; Fasano, S; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 14
INDEXED IN: 
Scopus WOS
Scopus WOS36
TITLE: The diagnosis and management of the haematologic manifestations of lupus Full Text
AUTHORS: Alba Velo Garcia; Sara Guerreiro Castro; David A Isenberg;
PUBLISHED: 2016, SOURCE: JOURNAL OF AUTOIMMUNITY, VOLUME: 74
AUTHORS: Alba Velo Garcia; Sara Guerreiro Castro; David A Isenberg;
PUBLISHED: 2016, SOURCE: JOURNAL OF AUTOIMMUNITY, VOLUME: 74
INDEXED IN: WOS
WOS37
TITLE: Profile of atacicept and its potential in the treatment of systemic lupus erythematosus Full Text
AUTHORS: Estafania Cogollo; Marta A Amaral Silva; David Isenberg;
PUBLISHED: 2015, SOURCE: DRUG DESIGN DEVELOPMENT AND THERAPY, VOLUME: 9
AUTHORS: Estafania Cogollo; Marta A Amaral Silva; David Isenberg;
PUBLISHED: 2015, SOURCE: DRUG DESIGN DEVELOPMENT AND THERAPY, VOLUME: 9
INDEXED IN: Scopus WOS
Scopus WOS38
TITLE: B-cell survival factors in autoimmune rheumatic disorders
AUTHORS: Sandra A Morais; Andreia Vilas Boas; David A Isenberg;
PUBLISHED: 2015, SOURCE: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, VOLUME: 7, ISSUE: 4
AUTHORS: Sandra A Morais; Andreia Vilas Boas; David A Isenberg;
PUBLISHED: 2015, SOURCE: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, VOLUME: 7, ISSUE: 4
39
TITLE: Assessment of long-term remission in lupus nephritis patients: a retrospective analysis over 30 years
AUTHORS: Marisa Fernandes das Neves; Rajendra Vara Prasad Irlapati; David Isenberg;
PUBLISHED: 2015, SOURCE: RHEUMATOLOGY, VOLUME: 54, ISSUE: 8
AUTHORS: Marisa Fernandes das Neves; Rajendra Vara Prasad Irlapati; David Isenberg;
PUBLISHED: 2015, SOURCE: RHEUMATOLOGY, VOLUME: 54, ISSUE: 8
40
TITLE: Longer duration of B cell depletion is associated with better outcome
AUTHORS: Sofia Sapeta Dias; Veronica Rodriguez Garcia; Nguyen, H; Charis Pericleous; David Isenberg;
PUBLISHED: 2015, SOURCE: RHEUMATOLOGY, VOLUME: 54, ISSUE: 10
AUTHORS: Sofia Sapeta Dias; Veronica Rodriguez Garcia; Nguyen, H; Charis Pericleous; David Isenberg;
PUBLISHED: 2015, SOURCE: RHEUMATOLOGY, VOLUME: 54, ISSUE: 10
